Viewing StudyNCT00171886



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00171886
Status: COMPLETED
Last Update Posted: 2017-02-24
First Post: 2005-09-13

Brief Title: Octreotide Efficacy and Safety in First-line Acromegalic Patients
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Acromegaly
Keywords:
Name View
Acromegaly View
Otreotide View
Tumor reduction View